Laura De Torres

ORCID: 0000-0003-1670-008X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Health disparities and outcomes
  • Urban Transport and Accessibility
  • Rheumatoid Arthritis Research and Therapies
  • MicroRNA in disease regulation
  • Migraine and Headache Studies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • RNA Interference and Gene Delivery
  • Aging and Gerontology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Peripheral Neuropathies and Disorders
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Psychosomatic Disorders and Their Treatments
  • Traumatic Brain Injury Research
  • Mental Health and Psychiatry
  • Trigeminal Neuralgia and Treatments
  • Effects of Vibration on Health
  • Occupational Health and Safety in Workplaces
  • Assembly Line Balancing Optimization
  • Cardiac Arrest and Resuscitation
  • Chronic Disease Management Strategies
  • Older Adults Driving Studies
  • Circular RNAs in diseases
  • Palliative Care and End-of-Life Issues
  • Neurology and Historical Studies

Hospital Universitario de Torrejón
2020-2024

Fondazione IRCCS Istituto Neurologico Carlo Besta
2017

Istituti di Ricovero e Cura a Carattere Scientifico
2017

To comprehensively identify the determinants of quality life (QoL) in a population study sample persons aged 18-50 and 50+.In this observational, cross-sectional study, QoL was measured with WHOQOL-AGE, brief instrument designed to measure older adults. Eight hierarchical regression models were performed QoL. Variables entered following order: Sociodemographic; Health Habits; Chronic Conditions; State description; Vision Hearing; Social Networks; Built Environment. In final model,...

10.1371/journal.pone.0159293 article EN cc-by PLoS ONE 2016-07-19

Chronic Migraine (CM) is a disabling condition, worsened when associated with Medication Overuse (MO). Mindfulness an emerging technique, effective in different pain conditions, but it has yet to be explored for CM-MO. We report the results of study assessing one-year course patients' status, hypothesis that effectiveness mindfulness-based approach would similar conventional prophylactic treatments.Patients CM-MO (code 1.3 and 8.2 International Classification Headache Disorders-3Beta)...

10.1186/s10194-017-0728-z article EN cc-by The Journal of Headache and Pain 2017-02-04

Abstract Objective Patients with Disorders of consciousness, are persons extremely low functioning levels and represent a challenge for health care systems due to their high needs facilitating environmental factors. Despite common Italian pathway these patients, no studies have analyzed information on how each region implemented it in its welfare system correlating data patients’ clinical outcomes. Materials Methods A multicenter observational pilot study was realized. Clinicians collected...

10.1002/brb3.740 article EN cc-by Brain and Behavior 2017-07-21

Purpose: This cross-sectional study aims to identify the predictors of work-related difficulties in a sample employed persons with multiple sclerosis as addressed Multiple Sclerosis Questionnaire for Job Difficulties. Materials and methods: Hierarchical linear regression analysis was conducted work difficulties: included demographic variables (age, formal education), disease duration severity, perceived disability psychological (cognitive dysfunction, depression anxiety). The targets were...

10.1080/09638288.2018.1461937 article EN Disability and Rehabilitation 2018-04-16

Background MicroRNAs are small non-coding RNA that regulate gene expression at a post-transcriptional level affecting several cellular processes including inflammation, neurodegeneration and remyelination. Different patterns of miRNAs have been demonstrated in multiple sclerosis compared to controls, as well different courses the disease. For these reason they postulated promising biomarkers candidates sclerosis. Objective correlate serum microRNAs profile with disability, cognitive...

10.3389/fimmu.2022.904683 article EN cc-by Frontiers in Immunology 2022-06-14

MicroRNAs (miRNAs) are promising biomarkers in multiple sclerosis (MS). This study aims to investigate the association between a preselected list of miRNAs serum with therapeutic response Glatiramer Acetate (GA) and clinical evolution cohort relapsing–remitting MS (RRMS) patients. We conducted longitudinal for 5 years, cut-off points at 2 including 26 RRMS patients treated GA least 6 months. A total from previous (miR-9.5p, miR-126.3p, mir-138.5p, miR-146a.5p, miR-200c.3p, miR-223.3p) were...

10.3390/biomedicines11102760 article EN cc-by Biomedicines 2023-10-12

Brain atrophy is associated with physical disability in multiple sclerosis (MS), but there a great variability between different studies and methodologies, its use still limited to research projects. We aimed analyze the relationship several volumetric measurements cognitive functioning MS patients clinical practice setting.This cross-sectional study. A total of 41 (31 relapsing-remitting MS, 6 secondary-progressive 4 primary-progressive MS) were included. Whole brain volume (WBV), gray...

10.32598/bcn.2021.1893.1 article EN cc-by-nc Basic and Clinical Neuroscience Journal 2021-06-28

La esclerosis múltiple (EM) es una enfermedad crónica y neurodegenerativa del Sistema Nervioso Central con clara prevalencia de alteraciones cognitivas, especialmente atención, memoria funciones ejecutivas. Los estudios volumetría han mostrado la estrecha relación entre el volumen cerebral rendimiento cognitivo, sin embargo, son pocos los trabajos que analizado las ejecutivas en profundidad. Por ello, objetivo presente trabajo fue esclarecer estas variables, a través medidas global regional...

10.14198/dcn.2020.7.1.04 article ES cc-by Revista de Discapacidad Clínica y Neurociencias 2020-07-15
Coming Soon ...